Home

Pakiet 1 natalizumab

Deadline:17 Jun 2024, 00:00 CEST

Tender information

TED EU

Warszawa, Poland

Type
16
Procedure
open
Ref. number
296727-2024
CPV
33600000

Pakiet 1 natalizumab, Pakiet 2 awalglukozydaza alfa

Show all tender information

Documents

Show all important dates